← GE HealthCare Technologies Inc.
| Annual Trend | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Current assets | $8.3b | $9.4b | $9.9b | $12.5b | |
| Cash, cash equivalents, and restricted cash | $1.4b | $2.5b | $2.9b | $4.5b | |
| Receivables – net of allowances of $103 and $103 | $3.3b | $3.6b | $3.6b | $4.0b | |
| Inventories | $2.2b | $2.0b | $1.9b | $2.2b | |
| All other current assets | $417.0m | $389.0m | $529.0m | $726.0m | |
| Property, plant, and equipment – net | $2.3b | $2.5b | $2.5b | $3.1b | |
| Goodwill | $12.8b | $12.9b | $13.1b | $13.5b | |
| Other intangible assets – net | $1.5b | $1.3b | $1.1b | $1.1b | |
| Contract and other deferred assets | $989.0m | $1.0b | $974.0m | $1.1b | |
| Deferred income taxes | $370.0m | $68.0m | $56.0m | $193.0m | |
| All other non-current assets | $1.0b | $1.9b | $1.9b | $2.2b | |
| Short-term borrowings | $15.0m | $1.0b | $1.5b | $508.0m | |
| Contract liabilities | $1.9b | $1.9b | $1.9b | $2.1b | |
| Current compensation and benefits | — | $1.5b | $1.5b | $1.7b | |
| All other current liabilities | $2.3b | $3.1b | $1.6b | $1.6b | |
| Long-term borrowings | $8.2b | $8.4b | $7.4b | $9.5b | |
| Non-current compensation and benefits | $549.0m | $5.8b | $5.6b | $5.5b | |
| All other non-current liabilities | $1.6b | $1.9b | $1.8b | $2.1b | |
| Total equity attributable to GE HealthCare | $9.4b | $7.1b | $8.4b | $10.4b | |
| Total equity | $9.4b | $7.1b | $8.5b | $10.4b | |
| Total assets | $27.5b | $32.5b | $33.1b | $36.9b | |
| Current liabilities | $7.2b | $9.0b | $9.6b | $9.1b | |
| Accounts payable | $2.9b | $2.9b | $3.0b | $3.2b | |
| Total liabilities | $17.9b | $25.1b | $24.4b | $26.3b | |
| Redeemable noncontrolling interests | $230.0m | $165.0m | $188.0m | $209.0m | |
| Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 458,844,209 shares issued as of December 31, 2025; 457,246,971 shares issued as of December 31, 2024 | $0.00 | $5,000,000.00 | $5,000,000.00 | $5,000,000.00 | |
| Treasury stock, at cost, 3,107,626 shares as of December 31, 2025 and 291,053 shares as of December 31, 2024 | — | $0 | ($25.0m) | ($225.0m) | |
| Additional paid-in capital | $0 | $6.5b | $6.6b | $6.7b | |
| Retained earnings | $0 | $1.3b | $3.3b | $5.3b | |
| Accumulated other comprehensive income (loss) – net | ($1.9b) | ($691.0m) | ($1.4b) | ($1.4b) | |
| Noncontrolling interests | $5.0m | $12.0m | $18.0m | $11.0m | |
| Total liabilities, redeemable noncontrolling interests, and equity | $27.5b | $32.5b | $33.1b | $36.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.